Evidence map›Paper›PMID 31533829›Full record

ArticleRespiratory research2019

Prevalence and course of disease after lung resection in primary ciliary dyskinesia: a cohort & nested case-control study.

Panayiotis Kouis, Myrofora Goutaki, Florian S Halbeisen, Ifigeneia Gioti, Nicos Middleton, Israel Amirav, Israeli PCD Consortium, Angelo Barbato, Italian PCD Consortium, Laura Behan and 25 more

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in Respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03517865 (International Primary Ciliary Dyskinesia Cohort), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03517865 active not recruitingnot on this map

International Primary Ciliary Dyskinesia Cohort

TypeobservationalSponsorUniversity of BernRan2013 to 2080Enrolled3,400ConditionsPrimary Ciliary Dyskinesia, Kartagener Syndrome
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. The RaDiCo information system for rare disease cohorts.Orphanet journal of rare diseases · 2025
    Article
  4. Lung Transplantation for Primary Ciliary Dyskinesia and Kartagener Syndrome: A Multicenter Study.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  5. Article
  6. Observational
  7. Article
  8. Motile ciliopathies.Nature reviews. Disease primers · 2020
    Review
  9. Article
  10. Review
  11. Proceedings of the 4BMC proceedings · 2020
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 16 institutions in 15 countries.

Panayiotis KouisRespiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus.
Myrofora GoutakiInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Florian S HalbeisenInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Ifigeneia GiotiRespiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus.
Nicos MiddletonDepartment of Nursing, School of Health Sciences, Cyprus University of Technology, Limassol, Cyprus.
Israel AmiravDepartment of Pediatrics University of Alberta Edmonton, Edmonton, Canada.
Israeli PCD Consortium
Angelo BarbatoPrimary Ciliary Dyskinesia Centre, Department of Women's and Children's Health (SDB), University of Padova, Padova, Italy.
Italian PCD Consortium
Laura BehanPrimary Ciliary Dyskinesia Centre, University Hospital Southampton, NHS Foundation Trust and University of Southampton, Southampton, UK.
Mieke BoonDepartment of Paediatrics & Paediatric Pulmonology, University Hospital Gasthuisberg Leuven, Leuven, Belgium.
Nagehan EmiraliogluPediatric Pulmonology, Hacettepe University, Ankara, Turkey.
Eric G HaarmanDepartment of pediatric pulmonology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.
Bulent KaradagDepartment of Pediatric Pulmonology, Marmara University, School of Medicine, Istanbul, Turkey.
Cordula Koerner-RettbergDepartment of Paediatric Pulmonology, University Children's Hospital of Ruhr University Bochum, Bochum, Germany.
Romain LazorDepartment of Respiratory Medicine, Lausanne University Hospital, Lausanne, Switzerland.
Swiss PCD Group
Michael R LoebingerHost Defence Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Bernard MaitreHopital intercommunal de Créteil, Service de Pneumologie, DHU ATVB, Université Paris Est Créteil, Paris, France.
French Reference Centre for Rare Lung Diseases
Henryk MazurekKlinika Pneumonologii i Mukowiscydozy, Instytut Gruźlicy i ChoróbPłuc, Rabka, Poland.
Lucy MorganDepartment of Respiratory Medicine, Concord Hospital Clinical School, University of Sydney, Sydney, Australia.
Kim Gjerum NielsenDanish PCD Centre Copenhagen, Paediatric Pulmonary Service, Copenhagen University Hospital, Copenhagen, Denmark.
Heymut OmranDepartment of General Paediatrics and Adolescent Medicine, University Hospital Muenster, Muenster, Germany.
Ugur ÖzçelikPediatric Pulmonology, Hacettepe University, Ankara, Turkey.
Mareike PriceClinic for Paediatric pulmonology, Allergiology and Neonatology, Hannover Medical School, Hannover, Germany.
Andrzej PogorzelskiKlinika Pneumonologii i Mukowiscydozy, Instytut Gruźlicy i ChoróbPłuc, Rabka, Poland.
Deborah SnijdersPrimary Ciliary Dyskinesia Centre, Department of Women's and Children's Health (SDB), University of Padova, Padova, Italy.
PCD Italian Consortium
Guillaume ThouveninService de pneumologie pédiatrique, Hôpital Trousseau, APHP, Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, Paris, France.
French Reference Centre for Rare Lung Diseases
Claudius WernerDepartment of General Paediatrics and Adolescent Medicine, University Hospital Muenster, Muenster, Germany.
Zorica ZivkovicChildren's Hospital for Lung Diseases and TB, Medical Centre "Dr Dragisa Misovic", Belgrade, Serbia.
Claudia E KuehniInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Panayiotis K YiallourosRespiratory Physiology Laboratory, Medical School, University of Cyprus, Nicosia, Cyprus. pyiall01@ucy.ac.cy.
University of Bern · CHUniversity of Padua · ITEmma Kinderziekenhuis · NLMedizinische Hochschule Hannover · DEThe University of Sydney · AUUniversitair Ziekenhuis Leuven · BEUniversité Paris-Est Créteil · FRUniversity Hospitals of the Ruhr-University of Bochum · DEUniversity of Cyprus · CYCopenhagen University Hospital · DKCyprus University of Technology · CYInserm · FRRoyal Brompton & Harefield NHS Foundation Trust · GBUniversity Hospital Münster · DEUniversity of Alberta · CAUniversity of Novi Sad · RS

Funding

FP7 Health 305404Ministry of Science Republic of Serbia III 41004Swiss National Science Foundation SNF 320030_173044
6 · The paper itself

Abstract

backgroundLung resection is a controversial and understudied therapeutic modality in Primary Ciliary Dyskinesia (PCD). We assessed the prevalence of lung resection in PCD across countries and compared disease course in lobectomised and non-lobectomised patients.

methodsIn the international iPCD cohort, we identified lobectomised and non-lobectomised age and sex-matched PCD patients and compared their characteristics, lung function and BMI cross-sectionally and longitudinally.

resultsAmong 2896 patients in the iPCD cohort, 163 from 20 centers (15 countries) underwent lung resection (5.6%). Among adult patients, prevalence of lung resection was 8.9%, demonstrating wide variation among countries. Compared to the rest of the iPCD cohort, lobectomised patients were more often females, older at diagnosis, and more often had situs solitus. In about half of the cases (45.6%) lung resection was performed before presentation to specialized PCD centers for diagnostic work-up. Compared to controls (n = 197), lobectomised patients had lower FVC z-scores (- 2.41 vs - 1.35, p = 0.0001) and FEV1 z-scores (- 2.79 vs - 1.99, p = 0.003) at their first post-lung resection assessment. After surgery, lung function continued to decline at a faster rate in lobectomised patients compared to controls (FVC z-score slope: - 0.037/year Vs - 0.009/year, p = 0.047 and FEV1 z-score slope: - 0.052/year Vs - 0.033/year, p = 0.235), although difference did not reach statistical significance for FEV1. Within cases, females and patients with multiple lobe resections had lower lung function.

conclusionsPrevalence of lung resection in PCD varies widely between countries, is often performed before PCD diagnosis and overall is more frequent in patients with delayed diagnosis. After lung resection, compared to controls most lobectomised patients have poorer and continuing decline of lung function despite lung resection. Further studies benefiting from prospective data collection are needed to confirm these findings.

Indexed as

AdolescentAdultBody Mass IndexCase-Control StudiesChildChild, PreschoolCiliary Motility DisordersCohort StudiesCross-Sectional StudiesFemaleForced Expiratory VolumeHumansLongitudinal StudiesLungMalePrevalenceCiliary motility disorders (MeSH)Kartagener syndrome (MeSH)Lobectomy

Identifiers

PMID31533829
PMCPMC6751891
OpenAlexW2974467694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.